We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

136 hedge funds and large institutions have $531M invested in VanEck Pharmaceutical ETF in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 50 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $516M → $531M (+$15M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 142 → 136 (-6)

9.6% less ownership

Funds ownership: 87.95% → 78.35% (-9.6%)

20% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 25

28% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 50

97% less call options, than puts

Call options by funds: $1.67M | Put options by funds: $64.7M

Holders
136
Holders Change
-6
Holders Change %
-4.23%
% of All Funds
1.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
20
Increased
36
Reduced
50
Closed
25
Calls
$1.67M
Puts
$64.7M
Net Calls
-$63.1M
Net Calls Change
-$59.9M

Top Buyers

Rank Fund Capital Flow
1
Fisher Asset Management
Fisher Asset Management
Washington
+$115M
2
UBS Group
UBS Group
Switzerland
+$18.5M
3
QC
Quadrature Capital
United Kingdom
+$11.5M
4
Bank of America
Bank of America
North Carolina
+$6.2M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$4.5M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$102M
2
MTWSIF
Mivtachim The Workers Social Insurance Fund
Israel
-$17.3M
3
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$13.2M
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$11.9M
5
Two Sigma Investments
Two Sigma Investments
New York
-$8.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
Cetera Investment Advisers
26
Cetera Investment Advisers
Illinois
$3.16M -$285K -3,166 -8%
Jane Street
27
Jane Street
New York
$2.65M +$898K +9,975 +52%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$2.38M -$1.62M -17,964 -41%
AGC
29
Aspen Grove Capital
Colorado
$2.34M – – –
Raymond James Financial
30
Raymond James Financial
Florida
$1.83M +$425K +4,721 +31%
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$1.7M +$59.4K +660 +4%
FF
32
Fluent Financial
Texas
$1.54M +$1.52M +16,923 New
SPIA
33
Steward Partners Investment Advisory
New York
$1.47M -$502K -5,577 -26%
Bank of Montreal
34
Bank of Montreal
Ontario, Canada
$1.42M -$629K -6,989 -31%
EH
35
Equitable Holdings
New York
$1.28M -$149K -1,649 -11%
IMC Chicago
36
IMC Chicago
Illinois
$1.11M +$164K +1,821 +18%
Osaic Holdings
37
Osaic Holdings
Arizona
$1.11M -$3.85M -42,770 -78%
Stifel Financial
38
Stifel Financial
Missouri
$1.04M +$5.49K +61 +0.5%
OC
39
Oppenheimer & Co
New York
$992K -$210K -2,327 -18%
CH
40
Canton Hathaway
Rhode Island
$911K +$901K +10,000 New
NAM
41
NTV Asset Management
West Virginia
$836K +$132K +1,463 +19%
William Blair & Company
42
William Blair & Company
Illinois
$834K -$6.84K -76 -0.8%
FFL
43
Financial Freedom LLC
Ohio
$819K -$135K -1,500 -14%
NA
44
NewEdge Advisors
Louisiana
$809K +$54.7K +607 +7%
BHBT
45
Burke & Herbert Bank & Trust
Virginia
$808K – – –
AWM
46
Axxcess Wealth Management
California
$793K +$359K +3,985 +85%
JP Morgan Chase
47
JP Morgan Chase
New York
$790K -$239K -2,650 -23%
PPG
48
Peak Planning Group
Colorado
$789K -$127K -1,415 -14%
DAS
49
Dynamic Advisor Solutions
Arizona
$679K +$671K +7,447 New
Northwestern Mutual Wealth Management
50
Northwestern Mutual Wealth Management
Wisconsin
$660K +$500K +5,553 +330%
1
2
3 4 5

PPH Hedge Fund Activity: Q1 2025 in Review

136 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q1 2025, worth a combined $531M — up 2.9% from $516M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of PPH and 20 opened new positions — a net loss of 5 holders — while 50 trimmed existing stakes and 36 added.

The largest buyer was Fisher Asset Management, opening a new position worth an estimated $115M. The largest seller was Goldman Sachs, cutting an estimated $102M.

  • 136 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q1 2025, down from 142 in Q4 2024.
  • Funds reported $531M of VanEck Pharmaceutical ETF stock for Q1 2025, up 2.9% quarter-over-quarter.
  • 20 funds opened new VanEck Pharmaceutical ETF positions in Q1 2025 and 25 closed out, a net change of -5 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q1 2025 was Fisher Asset Management, an estimated $115M added.
  • The largest VanEck Pharmaceutical ETF seller in Q1 2025 was Goldman Sachs, an estimated $102M sold.

Based on aggregated 13F filings for Q1 2025.